These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4031114)

  • 21. Addition of metolazone to overcome tolerance to furosemide in infants with bronchopulmonary dysplasia.
    Segar JL; Robillard JE; Johnson KJ; Bell EF; Chemtob S
    J Pediatr; 1992 Jun; 120(6):966-73. PubMed ID: 1593359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of furosemide and metolazone in the treatment of severe congestive heart failure.
    Grosskopf I; Rabinovitz M; Rosenfeld JB
    Isr J Med Sci; 1986 Nov; 22(11):787-90. PubMed ID: 3793436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dose-response relationship of bumetanide in healthy subjects].
    Baethke VR; Kampf D
    Arzneimittelforschung; 1975 Apr; 25(4):666-8. PubMed ID: 1174085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of combinations of diuretics in nephrotic edema.
    Garin EH
    Am J Dis Child; 1987 Jul; 141(7):769-71. PubMed ID: 3296741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.
    Roberts CJ; Homeida M; Roberts F; Bogie W
    Br J Clin Pharmacol; 1978 Aug; 6(2):129-33. PubMed ID: 678389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bumetanide-induced diuresis and natriuresis: effect of prostaglandin synthetase inhibition.
    Kaufman J; Hamburger R; Matheson J; Flamenbaum W
    J Clin Pharmacol; 1981; 21(11):663-7. PubMed ID: 6802882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metolazone pharmacokinetics and pharmacodynamics in renal transplantation.
    Gehr TW; Sica DA; Brater DC; Wallace HJ; Davis J; Fakhry I
    Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):116-23. PubMed ID: 2071258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of a bioassay in healthy men to evaluate diuretic-spironolactone combinations.
    McInnes GT; Shelton JR; Perkins RM; Harrison IR; Clarke JM
    Br J Clin Pharmacol; 1983 May; 15(5):564-6. PubMed ID: 6860532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mineral excretion following furosemide compared with bumetanide therapy in premature infants.
    Shankaran S; Liang KC; Ilagan N; Fleischmann L
    Pediatr Nephrol; 1995 Apr; 9(2):159-62. PubMed ID: 7794709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diuretic evaluation of bumetanide (author's transl)].
    Barrientos Guzmán A; Ortuño de Solo MT
    Med Clin (Barc); 1979 Nov; 73(8):338-41. PubMed ID: 522529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the role of kidney kallikrein on bumetanide induced diuresis in rats.
    Olsen UB
    Acta Pharmacol Toxicol (Copenh); 1981 Nov; 49(5):321-6. PubMed ID: 6179386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diuretic effects on renal brush border membrane transport and metabolism.
    Egel J; Pfanstiel J; Puschett JB
    Life Sci; 1985 Nov; 37(18):1675-81. PubMed ID: 4058246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of ethacrynic acid, bumetanide, frusemide, spironolactone and ADH on electrolyte excretion in ponies.
    Alexander F
    J Vet Pharmacol Ther; 1982 Sep; 5(3):153-60. PubMed ID: 7143552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of loop diuretics in patients with chronic renal insufficiency.
    Voelker JR; Cartwright-Brown D; Anderson S; Leinfelder J; Sica DA; Kokko JP; Brater DC
    Kidney Int; 1987 Oct; 32(4):572-8. PubMed ID: 3430953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of bumetanide response in the dog: effect of indomethacin.
    Smith DE; Lau HS
    J Pharm Sci; 1983 Nov; 72(11):1298-302. PubMed ID: 6644592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of loop diuretics on carbohydrate metabolism and electrolyte excretion.
    Robinson DS; Nilsson CM; Leonard RF; Horton ES
    J Clin Pharmacol; 1981; 21(11):637-46. PubMed ID: 7040494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal electrolyte excretion pattern in response to bumetanide in healthy volunteers.
    Hutcheon DE; Vincent ME; Sandhu RS
    J Clin Pharmacol; 1981; 21(11):604-9. PubMed ID: 7338570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uncoupling of proximal sodium bicarbonate from sodium phosphate transport by bumetanide.
    Puschett JB; Sylk D; Teredesai PR
    Am J Physiol; 1978 Nov; 235(5):F403-8. PubMed ID: 727259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natriuretic effectiveness of bumetanide in rats with immature kidney function.
    Günther R; Kersten L; Bräunlich H
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):171-6. PubMed ID: 3592857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of indomethacin on the natriuretic and renin-stimulating effect of bumetanide in essential hypertension.
    Pedrinelli R; Magagna A; Arzilli F; Sassano P; Salvetti A
    Clin Pharmacol Ther; 1980 Dec; 28(6):722-31. PubMed ID: 7002429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.